Exploring NASDAQ:NBIX's quality characteristics.

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is suited for quality investing. Investors should of course do their own research, but we spotted NEUROCRINE BIOSCIENCES INC showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

A Deep Dive into NEUROCRINE BIOSCIENCES INC's Quality Metrics.

• NEUROCRINE BIOSCIENCES INC has achieved substantial revenue growth over the past 5 years, with a 33.13% increase. This signifies the company's ability to successfully capture market opportunities and generate sustained revenue growth.
• NEUROCRINE BIOSCIENCES INC demonstrates impressive performance in terms of ROIC excluding cash and goodwill, with a 22.89% ratio. This highlights the company's efficient utilization of capital and its focus on maximizing returns for investors.
• The Debt/Free Cash Flow Ratio of NEUROCRINE BIOSCIENCES INC stands at 0.2, reflecting the company's prudent capital structure and cash flow dynamics. This ratio highlights the company's ability to generate robust free cash flow relative to its debt obligations.
• NEUROCRINE BIOSCIENCES INC demonstrates consistent Profit Quality over the past 5 years, with a strong 208.0%. This indicates the company's ability to generate sustainable and reliable profits, showcasing its long-term profitability and financial stability.
• NEUROCRINE BIOSCIENCES INC has experienced impressive EBIT growth over the past 5 years, with 60.65% increase. This reflects the company's effective operational performance and highlights its potential for long-term financial success.
• The EBIT 5-year growth of NEUROCRINE BIOSCIENCES INC has outpaced its Revenue 5-year growth, reflecting the company's focus on optimizing its profitability and generating sustainable earnings. This trend underscores its strong financial management.

Fundamental Analysis Observations

ChartMill utilizes a proprietary algorithm to assign a Fundamental Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of fundamental indicators and properties.

We assign a fundamental rating of 8 out of 10 to NBIX. NBIX was compared to 581 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making NBIX a very profitable company, without any liquidiy or solvency issues. An interesting combination arises when we look at growth and value: NBIX is growing strongly while it also seems undervalued. With these ratings, NBIX could be worth investigating further for value and growth and quality investing!.

Our latest full fundamental report of NBIX contains the most current fundamental analsysis.

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Keep in mind

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.